INNOVATIVE EYEWEAR INC (LUCY) Fundamental Analysis & Valuation
NASDAQ:LUCY • US45791D2080
1.11 USD
+0.01 (+0.91%)
Last: Mar 5, 2026, 12:05 PM
This LUCY fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
LUCY gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 184 industry peers in the Health Care Equipment & Supplies industry. No worries on liquidiy or solvency for LUCY as it has an excellent financial health rating, but there are worries on the profitability. LUCY is valued quite expensively, but it does show have an excellent growth rating.
1. LUCY Profitability Analysis
1.1 Basic Checks
- In the past year LUCY has reported negative net income.
- LUCY had a negative operating cash flow in the past year.
- In the past 5 years LUCY always reported negative net income.
- In the past 5 years LUCY always reported negative operating cash flow.
1.2 Ratios
- Looking at the Return On Assets, with a value of -70.22%, LUCY is doing worse than 72.28% of the companies in the same industry.
- The Return On Equity of LUCY (-76.56%) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -70.22% | ||
| ROE | -76.56% | ||
| ROIC | N/A |
ROA(3y)-102.4%
ROA(5y)-213.8%
ROE(3y)-115.52%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- Looking at the Gross Margin, with a value of 22.83%, LUCY is doing worse than 79.89% of the companies in the same industry.
- LUCY's Gross Margin has declined in the last couple of years.
- The Profit Margin and Operating Margin are not available for LUCY so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 22.83% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-15.43%
GM growth 5YN/A
2. LUCY Health Analysis
2.1 Basic Checks
- LUCY does not have a ROIC to compare to the WACC, probably because it is not profitable.
- The number of shares outstanding for LUCY has been increased compared to 1 year ago.
- Compared to 5 years ago, LUCY has less shares outstanding
- LUCY has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
- Based on the Altman-Z score of -1.15, we must say that LUCY is in the distress zone and has some risk of bankruptcy.
- LUCY has a Altman-Z score (-1.15) which is in line with its industry peers.
- There is no outstanding debt for LUCY. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -1.15 |
ROIC/WACCN/A
WACC10.01%
2.3 Liquidity
- LUCY has a Current Ratio of 11.98. This indicates that LUCY is financially healthy and has no problem in meeting its short term obligations.
- With an excellent Current ratio value of 11.98, LUCY belongs to the best of the industry, outperforming 96.20% of the companies in the same industry.
- A Quick Ratio of 10.13 indicates that LUCY has no problem at all paying its short term obligations.
- LUCY's Quick ratio of 10.13 is amongst the best of the industry. LUCY outperforms 95.11% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 11.98 | ||
| Quick Ratio | 10.13 |
3. LUCY Growth Analysis
3.1 Past
- The Earnings Per Share has grown by an impressive 72.66% over the past year.
- LUCY shows a strong growth in Revenue. In the last year, the Revenue has grown by 53.21%.
- Measured over the past years, LUCY shows a very strong growth in Revenue. The Revenue has been growing by 33.36% on average per year.
EPS 1Y (TTM)72.66%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%61.62%
Revenue 1Y (TTM)53.21%
Revenue growth 3Y33.36%
Revenue growth 5YN/A
Sales Q2Q%163.46%
3.2 Future
- Based on estimates for the next years, LUCY will show a very strong growth in Earnings Per Share. The EPS will grow by 36.67% on average per year.
- LUCY is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 117.64% yearly.
EPS Next Y71.92%
EPS Next 2Y36.67%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year52.63%
Revenue Next 2Y117.64%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. LUCY Valuation Analysis
4.1 Price/Earnings Ratio
- LUCY reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
- Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for LUCY. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- A more expensive valuation may be justified as LUCY's earnings are expected to grow with 36.67% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y36.67%
EPS Next 3YN/A
5. LUCY Dividend Analysis
5.1 Amount
- No dividends for LUCY!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
LUCY Fundamentals: All Metrics, Ratios and Statistics
NASDAQ:LUCY (3/5/2026, 12:05:43 PM)
1.11
+0.01 (+0.91%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-13 2025-11-13/amc
Earnings (Next)N/A N/A
Inst Owners6.95%
Inst Owner Change5.36%
Ins Owners15.63%
Ins Owner Change-16.59%
Market Cap5.94M
Revenue(TTM)2.39M
Net Income(TTM)-7.85M
Analysts82.86
Price Target3.06 (175.68%)
Short Float %3.9%
Short Ratio0.05
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)19.97%
Min EPS beat(2)15.97%
Max EPS beat(2)23.97%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-38.87%
Min Revenue beat(2)-43.24%
Max Revenue beat(2)-34.5%
Revenue beat(4)0
Avg Revenue beat(4)-41.35%
Min Revenue beat(4)-55.39%
Max Revenue beat(4)-32.28%
Revenue beat(8)1
Avg Revenue beat(8)-18.57%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-40%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)6.81%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-27.5%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 2.48 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 0.58 | ||
| P/tB | 0.6 | ||
| EV/EBITDA | N/A |
EPS(TTM)-2.63
EYN/A
EPS(NY)-1.05
Fwd EYN/A
FCF(TTM)-1.49
FCFYN/A
OCF(TTM)-1.47
OCFYN/A
SpS0.45
BVpS1.92
TBVpS1.84
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -70.22% | ||
| ROE | -76.56% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 22.83% | ||
| FCFM | N/A |
ROA(3y)-102.4%
ROA(5y)-213.8%
ROE(3y)-115.52%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-15.43%
GM growth 5YN/A
F-Score3
Asset Turnover0.21
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 89.89% | ||
| Cap/Sales | 5.5% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 11.98 | ||
| Quick Ratio | 10.13 | ||
| Altman-Z | -1.15 |
F-Score3
WACC10.01%
ROIC/WACCN/A
Cap/Depr(3y)402.41%
Cap/Depr(5y)N/A
Cap/Sales(3y)23.82%
Cap/Sales(5y)37.77%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)72.66%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%61.62%
EPS Next Y71.92%
EPS Next 2Y36.67%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)53.21%
Revenue growth 3Y33.36%
Revenue growth 5YN/A
Sales Q2Q%163.46%
Revenue Next Year52.63%
Revenue Next 2Y117.64%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y0.87%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year6.33%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-29.6%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-34.43%
OCF growth 3YN/A
OCF growth 5YN/A
INNOVATIVE EYEWEAR INC / LUCY FAQ
Can you provide the ChartMill fundamental rating for INNOVATIVE EYEWEAR INC?
ChartMill assigns a fundamental rating of 4 / 10 to LUCY.
Can you provide the valuation status for INNOVATIVE EYEWEAR INC?
ChartMill assigns a valuation rating of 1 / 10 to INNOVATIVE EYEWEAR INC (LUCY). This can be considered as Overvalued.
What is the profitability of LUCY stock?
INNOVATIVE EYEWEAR INC (LUCY) has a profitability rating of 0 / 10.
Can you provide the expected EPS growth for LUCY stock?
The Earnings per Share (EPS) of INNOVATIVE EYEWEAR INC (LUCY) is expected to grow by 71.92% in the next year.